Actively Recruiting
Enhanced Recovery After Surgery (ERAS) Pathway Following Gynecological Oncology Surgery in a Tertiary Level Hospital: A Prospective Randomized Controlled Trial
Led by Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh · Updated on 2025-08-07
130
Participants Needed
1
Research Sites
8 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying the use of Enhanced Recovery After Surgery (ERAS) protocols in the management of gynecological oncology surgeries. ERAS is a multimodal care approach designed to speed up recovery after surgery by maintaining organ function and reducing surgical stress. This study compares ERAS to conventional surgical care to evaluate outcomes like hospital stay, pain, complications, and costs in patients with cervical, uterine, or ovarian cancer. Participants will be randomly assigned to one of two groups. The ERAS group will follow a protocol including patient education, no bowel preparation, controlled fasting, limited fluid use, opioid-sparing pain management, early catheter and drain removal, and encouragement of early movement and diet resumption. The conventional group will receive standard care with bowel preparation, longer fasting, more fluid use, narcotic analgesia, prolonged immobilization, and delayed diet and catheter removal. The study will run from April 2024 to March 2026, with 160 patients enrolled. During the study, researchers will assess factors such as hospital stay length (3 to 4 days), time to first bowel movement, pain levels, nausea, complications, readmission rates, mortality, and total hospital costs. Patients will be closely monitored through the preoperative, intraoperative, and postoperative phases. Data will be analyzed to determine the impact of ERAS on recovery and healthcare resource use compared to conventional methods.
CONDITIONS
Brief Title
Enhanced Recovery After Surgery(ERAS) Following Gynaecological Oncology Surgery in a Tertiary Level Hospital
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients between the age of 18-70 years
- Diagnosed case with cervical, uterine or ovarian cancer
- Admitted for surgical management
You will not qualify if you...
- Patients with severe comorbidity, including diabetes mellitus, chronic renal disease, chronic liver disease
- Patients with American Society of Anesthesiologists risk 64 4
- Severe organ dysfunction or failure
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day of surgery
Participants undergo gynecological oncology surgery with either the ERAS protocol or conventional methods, including preoperative preparation and intraoperative procedures.
1 visit (in-person)
Duration - Up to 3 to 4 days
Participants receive post-operative care including pain management, early mobilization, diet progression, and monitoring for complications according to their assigned protocol.
Daily visits during hospital stay
Duration - Up to 21 days after surgery
Participants are monitored for complications, readmission, pain, nausea, and overall recovery outcomes following surgery.
1 to 2 follow-up visits depending on recovery
Trial Site Locations
Total: 1 location
1
Jannat Ferdous
Dhaka, Bangladesh, 1000
Actively Recruiting
Research Team
D
DR.Jannatul Ferdous, professor
D
Dr.Shaheda Anwar, MBBS,PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here